Evidence map›Paper›PMID 37189867›Full record

ArticleChildren (Basel, Switzerland)2023

Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review.

Valerio Maniscalco, Rachele Niccolai, Edoardo Marrani, Ilaria Maccora, Federico Bertini, Ilaria Pagnini, Gabriele Simonini, Donatella Lasagni, Sandra Trapani, Maria Vincenza Mastrolia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Valerio ManiscalcoDepartment of Health Sciences, University of Florence, 50134 Firenze, Italy.ORCID 0000-0003-3287-846X
Rachele NiccolaiDepartment of Health Sciences, University of Florence, 50134 Firenze, Italy.ORCID 0009-0004-9970-1911
Edoardo MarraniRheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.
Ilaria MaccoraRheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.ORCID 0000-0001-6418-3254
Federico BertiniRadiology Unit, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.
Ilaria PagniniRheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.ORCID 0000-0002-4508-2017
Gabriele SimoniniRheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.ORCID 0000-0002-5919-4861
Donatella LasagniPediatric Unit, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.
Sandra TrapaniDepartment of Health Sciences, University of Florence, 50134 Firenze, Italy.
Maria Vincenza MastroliaRheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, 50139 Firenze, Italy.ORCID 0000-0002-9784-3543
Meyer Children's Hospital · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic hyperinflammatory disorder that is associated with a hypercoagulable state and a higher risk of thrombotic events (TEs). We report the case of a 9-year-old MIS-C patient with a severe course who developed a massive pulmonary embolism that was successfully treated with heparin. A literature review of previous TEs in MIS-C patients was conducted (60 MIS-C cases from 37 studies). At least one risk factor for thrombosis was observed in 91.7% of patients. The most frequently observed risk factors were pediatric intensive care unit hospitalization (61.7%), central venous catheter (36.7%), age >12 years (36.7%), left ventricular ejection fraction <35% (28.3%), D-dimer >5 times the upper limit of normal values (71.9%), mechanical ventilation (23.3%), obesity (23.3%), and extracorporeal membrane oxygenation (15%). TEs may concurrently affect multiple vessels, including both arterial and venous. Arterial thrombosis was more frequent, mainly affecting the cerebral and pulmonary vascular systems. Despite antithrombotic prophylaxis, 40% of MIS-C patients developed TEs. Over one-third of patients presented persistent focal neurological signs, and ten patients died, half of whom died because of TEs. TEs are severe and life-threatening complications of MIS-C. In case with thrombosis risk factors, appropriate thromboprophylaxis should be promptly administered. Despite proper prophylactic therapy, TEs may occur, leading in some cases to permanent disability or death.

Indexed as

disabilityheparinMIS-Cprophylaxisthrombosis

Identifiers

PMID37189867
PMCPMC10137057
OpenAlexW4361004719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.